Mostrar el registro sencillo del ítem
Neuroprotective effects of the catalytic subunit of telomerase: A potential therapeutic target in the central nervous system
dc.contributor.author | González-Giraldo Y. | |
dc.contributor.author | Forero D.A. | |
dc.contributor.author | Echeverria V. | |
dc.contributor.author | Gonzalez J. | |
dc.contributor.author | Ávila-Rodriguez M. | |
dc.contributor.author | Garcia-Segura L.M. | |
dc.contributor.author | Barreto G.E. | |
dc.date.accessioned | 2020-09-02T22:19:23Z | |
dc.date.available | 2020-09-02T22:19:23Z | |
dc.date.issued | 2016 | |
dc.identifier | 10.1016/j.arr.2016.04.004 | |
dc.identifier.citation | 28, , 37-45 | |
dc.identifier.issn | 15681637 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12728/4722 | |
dc.description | Senescence plays an important role in neurodegenerative diseases and involves key molecular changes induced by several mechanisms such as oxidative stress, telomere shortening and DNA damage. Potential therapeutic strategies directed to counteract these molecular changes are of great interest for the prevention of the neurodegenerative process. Telomerase is a ribonucleoprotein composed of a catalytic subunit (TERT) and a RNA subunit (TERC). It is known that the telomerase is involved in the maintenance of telomere length and is a highly expressed protein in embryonic stages and decreases in adult cells. In the last decade, a growing number of studies have shown that TERT has neuroprotective effects in cellular and animal models after a brain injury. Significantly, differences in TERT expression between controls and patients with major depressive disorder have been observed. More recently, TERT has been associated with the decrease in reactive oxygen species and DNA protection in mitochondria of neurons. In this review, we highlight the role of TERT in some neurodegenerative disorders and discuss some studies focusing on this protein as a potential target for neuroprotective therapies. © 2016 Elsevier B.V. | |
dc.language.iso | en | |
dc.publisher | Elsevier Ireland Ltd | |
dc.subject | Neuroprotection | |
dc.subject | Oxidative stress | |
dc.subject | Senescence | |
dc.subject | Telomerase | |
dc.subject | Telomeres | |
dc.subject | ags 499 | |
dc.subject | cotinine | |
dc.subject | estradiol | |
dc.subject | montelukast | |
dc.subject | neuroprotective agent | |
dc.subject | nicotine | |
dc.subject | raloxifene | |
dc.subject | tamoxifen | |
dc.subject | telomerase | |
dc.subject | tibolone | |
dc.subject | unclassified drug | |
dc.subject | neuroprotective agent | |
dc.subject | reactive oxygen metabolite | |
dc.subject | telomerase | |
dc.subject | astrocyte | |
dc.subject | brain nerve cell | |
dc.subject | cell aging | |
dc.subject | cellular distribution | |
dc.subject | central nervous system | |
dc.subject | degenerative disease | |
dc.subject | enzyme active site | |
dc.subject | enzyme activity | |
dc.subject | genetic variability | |
dc.subject | human | |
dc.subject | hypoxic ischemic encephalopathy | |
dc.subject | microglia | |
dc.subject | mitochondrial targeting signal | |
dc.subject | neuroprotection | |
dc.subject | nonhuman | |
dc.subject | oxidative stress | |
dc.subject | pleiotropy | |
dc.subject | protein expression | |
dc.subject | protein localization | |
dc.subject | protein phosphorylation | |
dc.subject | protein targeting | |
dc.subject | Review | |
dc.subject | senescence | |
dc.subject | telomere | |
dc.subject | telomere homeostasis | |
dc.subject | telomere shortening | |
dc.subject | aging | |
dc.subject | animal | |
dc.subject | central nervous system | |
dc.subject | DNA damage | |
dc.subject | drug effects | |
dc.subject | genetics | |
dc.subject | metabolism | |
dc.subject | Neurodegenerative Diseases | |
dc.subject | physiology | |
dc.subject | Aging | |
dc.subject | Animals | |
dc.subject | Central Nervous System | |
dc.subject | DNA Damage | |
dc.subject | Humans | |
dc.subject | Neurodegenerative Diseases | |
dc.subject | Neuroprotective Agents | |
dc.subject | Oxidative Stress | |
dc.subject | Reactive Oxygen Species | |
dc.subject | Telomerase | |
dc.subject | Telomere | |
dc.subject | Telomere Shortening | |
dc.title | Neuroprotective effects of the catalytic subunit of telomerase: A potential therapeutic target in the central nervous system | |
dc.type | Review |